Skip to main content

Lowell F. Satler, MD

06/19/2008
What is the Impella® Recover® LP 2.5 System? The Impella Recover LP 2.5 device is a percutaneous ventricular unloading catheter. This is a 12-French catheter, placed in the left ventricle, which utilizes a transaxial flow pump to transfer...
What is the Impella® Recover® LP 2.5 System? The Impella Recover LP 2.5 device is a percutaneous ventricular unloading catheter. This is a 12-French catheter, placed in the left ventricle, which utilizes a transaxial flow pump to transfer...
What is the Impella® Recover® LP...
06/19/2008
Cath Lab Digest
Original Contribution
09/05/2009
ABSTRACT: Background. Stents are used to treat the first and even successive episodes of in-stent restenosis (ISR). Methods. In 18 patients (19 lesions), intravascular ultrasound (IVUS) was performed after placement of a stent for a...
ABSTRACT: Background. Stents are used to treat the first and even successive episodes of in-stent restenosis (ISR). Methods. In 18 patients (19 lesions), intravascular ultrasound (IVUS) was performed after placement of a stent for a...
ABSTRACT: Background. Stents are...
09/05/2009
Journal of Invasive Cardiology
06/19/2008
Recently, the Washington Hospital Center presented a unique analysis on the clinical impact of intravascular ultrasound (IVUS) on drug-eluting stent (DES) placement at the 2007 annual meeting of the American Heart Association. What was the...
Recently, the Washington Hospital Center presented a unique analysis on the clinical impact of intravascular ultrasound (IVUS) on drug-eluting stent (DES) placement at the 2007 annual meeting of the American Heart Association. What was the...
Recently, the Washington...
06/19/2008
Cath Lab Digest
Original Contribution
06/28/2011
ABSTRACT: Background. The process of in-stent neointimal hyperplasia (NIH) between drug-eluting stents (DES) and bare metal stents (BMS) might be different. We compared in vivo composition of in-stent NIH between DES and BMS using virtual...
ABSTRACT: Background. The process of in-stent neointimal hyperplasia (NIH) between drug-eluting stents (DES) and bare metal stents (BMS) might be different. We compared in vivo composition of in-stent NIH between DES and BMS using virtual...
ABSTRACT: Background. The...
06/28/2011
Journal of Invasive Cardiology
Feature
06/19/2008
Use of eMedcon is focused around a facility-individualized website developed and hosted by Medcon. eMedcon software uploads angiographic and echo images for online access. Users might be referring physicians who wish to send images to...
Use of eMedcon is focused around a facility-individualized website developed and hosted by Medcon. eMedcon software uploads angiographic and echo images for online access. Users might be referring physicians who wish to send images to...
Use of eMedcon is focused around...
06/19/2008
Cath Lab Digest
Original Contribution
09/02/2015
This study compares the clinical outcomes of lesion preparation with rotational atherectomy, plain old balloon angioplasty, or cutting-balloon angioplasty in patients with heavily calcified coronary lesions who were treated with drug-eluting...
This study compares the clinical outcomes of lesion preparation with rotational atherectomy, plain old balloon angioplasty, or cutting-balloon angioplasty in patients with heavily calcified coronary lesions who were treated with drug-eluting...
This study compares the clinical...
09/02/2015
Journal of Invasive Cardiology
Feature
06/19/2008
What is the Impella® Recover® LP 2.5 System? The Impella Recover LP 2.5 device is a percutaneous ventricular unloading catheter. This is a 12-French catheter, placed in the left ventricle, which utilizes a transaxial flow pump to transfer...
What is the Impella® Recover® LP 2.5 System? The Impella Recover LP 2.5 device is a percutaneous ventricular unloading catheter. This is a 12-French catheter, placed in the left ventricle, which utilizes a transaxial flow pump to transfer...
What is the Impella® Recover® LP...
06/19/2008
Cath Lab Digest
Original Contribution
05/29/2015
This study aimed to evaluate the safety and efficacy of everolimus-eluting stent (EES) use compared with first-generation drug-eluting stent (DES) use in diabetic patients undergoing multivessel percutaneous coronary intervention. In diabetic...
This study aimed to evaluate the safety and efficacy of everolimus-eluting stent (EES) use compared with first-generation drug-eluting stent (DES) use in diabetic patients undergoing multivessel percutaneous coronary intervention. In diabetic...
This study aimed to evaluate the...
05/29/2015
Journal of Invasive Cardiology
Feature
06/19/2008
Recently, the Washington Hospital Center presented a unique analysis on the clinical impact of intravascular ultrasound (IVUS) on drug-eluting stent (DES) placement at the 2007 annual meeting of the American Heart Association. What was the...
Recently, the Washington Hospital Center presented a unique analysis on the clinical impact of intravascular ultrasound (IVUS) on drug-eluting stent (DES) placement at the 2007 annual meeting of the American Heart Association. What was the...
Recently, the Washington...
06/19/2008
Cath Lab Digest
Original Contribution
05/21/2014
A comparison of the long-term safety and clinical effectiveness of the Xience V everolimus-eluting stent to both the Taxus paclitaxel-eluting stent and the Cypher sirolimus-eluting stent in an unselected patient population.
A comparison of the long-term safety and clinical effectiveness of the Xience V everolimus-eluting stent to both the Taxus paclitaxel-eluting stent and the Cypher sirolimus-eluting stent in an unselected patient population.
A comparison of the long-term...
05/21/2014
Journal of Invasive Cardiology